Digest Spectrum
Natural health product licensed in Canada
- Licence holder
- Enzymedica Inc.
- NPN or DIN-HM
- 80033133
- Status
- Active licence
- Licence date
- 27 June 2012
- Revision date
- 31 January 2013
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bêta-D-galactoside galactohydrolase Source : Aspergillus flavus var. oryzae | 1,000 FCC ALU | Not calculated |
| Bêta-D-galactoside galactohydrolase Source : Aspergillus flavus var. oryzae | 10 mg | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger | 20 FCC AGU | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger | 20 mg | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger | 300 FCC GalU | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger | 30 mg | Not calculated |
| Diastase du malt Source : Hordeum vulgare | 100 FCC DP | Not calculated |
| Diastase du malt Source : Hordeum vulgare | 3 mg | Not calculated |
| Protéase Source : Aspergillus niger | 70,938 FCC HUT | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae | 70,938 FCC HUT | Not calculated |
| bêta-D-fructofuranoside fructohydrolase Source : Saccharomyces cerevisae | 75 FCC SU | Not calculated |
| bêta-D-fructofuranoside fructohydrolase Source : Saccharomyces cerevisae | 1 mg | Not calculated |
Non-medicinal ingredients
cellulose, Eau purifiée, xylanase
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Protease helps digest proteins. Digestive aid. Alpha-galactosidase helps reduce gas production/flatulence following a meal rich in fermentable carbohydrates. Alpha-galactosidase helps prevent gastrointestinal intolerance of oligosaccharides/fermentable carbohydrates. Digestive enzymes.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80033133
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2013. Photograph the packaging to check whether it has changed. Photograph the packaging